GlassScriptPhysician profile
Farbod Masrour
NPI 1902191455
$2,630.70
in general payments reported to CMS, 2019-2025
19 companies · $397 in 2025
The $397 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $76.17 · 2021: $90.19 · 2022: $617 · 2023: $571 · 2024: $630 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $814 · Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $813.86 |
| Food and Beverage | $783.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $1,109.21 | 2019-2025 | Sutab, Suflave |
| Takeda Pharmaceuticals U.S.A., INC. | $269.16 | 2020-2024 | Entyvio |
| Vivus LLC | $249.49 | 2021-2024 | Qsymia, Pancreaze |
| Celgene Corporation | $231.31 | 2022-2024 | Zeposia |
| Redhill Biopharma INC. | $188.66 | 2020-2025 | Talicia, Movantik, Aemcolo |
| Medtronic USA, INC. | $127.46 | 2019 | |
| Ironwood Pharmaceuticals, INC | $98.24 | 2022-2024 | |
| Shionogi INC | $81.36 | 2019-2020 | |
| Cook Medical LLC | $59.32 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.90 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $38.77 | 2024-2025 | Voquezna |
| Abbvie INC. | $30.09 | 2023-2024 | |
| Medtronic, INC. | $21.45 | 2024 | Pillcam |
| Madrigal Pharmaceuticals | $15.80 | 2024 | Resmetirom |
| Fresenius Kabi USA, LLC | $15.75 | 2023 | Smoflipid |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.89 | 2023 | |
| Steris Corporation | $13.07 | 2021 | |
| Nestle Healthcare Nutrition INC. | $12.71 | 2022 | |
| Allergan, INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farbod Masrour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.